Physician profile
Amit Prasad
NPI 1902067341
$1,694.19
in general payments reported to CMS, 2019-2025
10 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $128 · 2021: $177 · 2022: $482 · 2023: $232 · 2024: $50.81 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $420.12 | 2019-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $416.82 | 2019-2025 | |
| Pfizer INC. | $193.48 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.04 | 2025 | Jardiance |
| Edwards Lifesciences Corporation | $145.48 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $144.83 | 2023-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.98 | 2021-2024 | Lifevest |
| Avinger INC. | $40.49 | 2021-2022 | |
| Abbott Laboratories | $37.05 | 2022-2025 | Jot Dx |
| Kestra Medical Technology Services, INC. | $35.90 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.